MRGPRX2 INHIBITOR
AB102 is an investigational, oral, small molecule that inhibits MRGPRX2, a mast-cell specific receptor that drives inflammation underlying certain allergic diseases. By inhibiting MRGPRX2, AB102 is designed to block mast cell degranulation and subsequent inflammatory responses.
